BioMarin Pharmaceutical, Inc. (NASDAQ:BMRN) Q2 2017 Earnings Call August 02, 2017 4:30 pm ET Executives Traci McCarty - BioMarin Pharmaceutical, Inc. Jean-Jacques Bienaimé - BioMarin Pharmaceutical, Inc. Jeffrey Robert Ajer - BioMarin Pharmaceutical, Inc. Daniel K. Spiegelman - BioMarin Pharmaceutical, Inc. Henry J. Fuchs, M.D. - BioMarin Pharmaceutical, Inc. Robert A. Baffi - BioMarin Pharmaceutical, Inc. Analysts Phil Nadeau - Cowen & Co. LLC Cory W. Kasimov - JPMorgan Securities LLC Christopher Raymond - Raymond James & Associates, Inc. Andrew Peters - Deutsche Bank Securities, Inc. Alethia Young - Credit Suisse Securities (NYSE:USA) LLC Matthew K. Harrison - Morgan Stanley &...
↧